This cover was created as a submission to a design competition hosted by The Economist, which invited participants to design an alternate cover and headline for the magazine’s cover story on GLP-1 receptor agonists — medications originally developed for diabetes that are now demonstrating broader medical potential, including treatment for Alzheimer’s disease and substance use disorders. My concept, titled “The Master Key,” visualized how these drugs are unlocking a seemingly endless array of therapeutic applications.

Out of 160 submissions, my design was selected as one of seven finalists. You can view the other shortlisted entries (and read the original editorial) here.